|
2024
|
Invention
|
Combination preparation comprising statin and cilostazol. A combination preparation is provided a... |
|
|
Invention
|
Sustained-release mosapride formulation. The present invention relates to a sustained-release for... |
|
2023
|
Invention
|
Pharmaceutical composition for thyroid protection, and preparation method therefor. A pharmaceuti... |
|
|
Invention
|
Method for preparing dactinomycin-containing pharmaceutical composition having improved solubilit... |
|
2022
|
Invention
|
Pharmaceutical composition comprising rabeprazole and sodium bicarbonate. The present invention r... |
|
2021
|
Invention
|
Inhalable pharmaceutical composition for prevention or treatment of coronavirus disease 2019 (cov... |
|
|
Invention
|
Pharmaceutical composition for prevention or treatment of coronavirus infection disease-19. The p... |
|
|
Invention
|
Sustained-release metformin coated tablet having controlled release by osmotic pressure. A sustai... |
|
|
Invention
|
Combination drug comprising mosapride and proton pump inhibitor. The present invention relates to... |
|
|
Invention
|
Hard capsule agent comprising enteric proton pump inhibitor and mosapride sustained-release formu... |
|
|
Invention
|
Pharmaceutical composition including r-thioctic acid or pharmaceutically acceptable salt thereof ... |
|
|
Invention
|
Pharmaceutical composition comprising r-thioctic acid or pharmaceutically acceptable salt thereof... |
|
|
Invention
|
Pharmaceutical composition including r-thioctic acid or pharmaceutically acceptable salt thereof,... |
|
2020
|
Invention
|
Core tablet formulation containing proton pump inhibitor and mosapride. The present invention rel... |
|
|
Invention
|
Core tablet preparation comprising proton pump inhibitor and mosapride. The present invention rel... |
|
|
Invention
|
Small-sized, sustained release pharmaceutical composition comprising choline alfoscerate. The pre... |
|
|
Invention
|
Sustained-release, small-sized orally administered preparation containing choline alfoscerate. Th... |
|
|
Invention
|
Pharmaceutical composition comprising aceclofenac and method for preparing same. The present inve... |
|
|
Invention
|
Method for preparation of levodropropizine-containing, sustained-release tablet. The present inve... |
|
2019
|
Invention
|
Pharmaceutical composition containing extract of pelargonium sidoides, and preparation method the... |
|
|
Invention
|
Pharmaceutical composition comprising cilostazol and statin-based drug. The present invention rel... |
|
|
Invention
|
Enteric coated tablet comprising fenofibric acid or pharmaceutically acceptable salt thereof. The... |
|
|
Invention
|
Method for preparing organic solvent-free lyophilized cyclophosphamide. The present invention rel... |
|
|
Invention
|
Method for preparing organic solvent-free lyophilized cyclophosphamide. The present inventi... |
|
|
Invention
|
Method for preparing lyophilized cyclophosphamide without using organic solvent. The present inve... |
|
|
Invention
|
Sustained-release formulation of cilostazol. The present invention relates to a sustained-release... |
|
|
P/S
|
Drugs for medical purposes; pharmaceutical preparations;
bronchodilating preparations; nervines;... |
|
2018
|
Invention
|
Pharmaceutical composition comprising tha as effective ingredient for treatment of prostate cance... |
|
|
Invention
|
Liquid syrup preparation containing choline alfoscerate. The present invention pertains to: a liq... |
|
|
Invention
|
Core tablet composite preparation comprising mosapride and rabeprazole. The present invention rel... |
|
|
Invention
|
Complex formulation comprising aceclofenac and esomeprazole and method of preparing same. The pre... |
|
2017
|
Invention
|
Pharmaceutical composition comprising tha as active ingredient for treating breast cancer. Provid... |
|
|
Invention
|
Pharmaceutical composition comprising tha as active ingredient for treating breast cancer. The pr... |
|
|
Invention
|
Dry powder inhaler with drug inlet mesh network. The present invention relates to a dry powder in... |
|
|
Invention
|
Dry powder inhaler. The present invention relates to a dry powder inhaler. The present invention ... |
|
|
Invention
|
Composite preparation containing clopidogrel and aspirin. The present invention relates to a comp... |
|
|
Invention
|
Pharmaceutical composition for oral administration comprising (±)-2-[2-(3-carboxypropionyloxy)-3-... |
|
|
Invention
|
Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof ... |
|
|
Invention
|
Oral composite formulation comprising fat-soluble drug and solid preparation coated with oil repe... |
|
2016
|
Invention
|
Method for preparing lyophilized organic solvent-free cyclophosphamide.
The present invention re... |
|
|
Invention
|
A method for preparing lyophilized organic solvent-free cyclophosphamide. The present inven... |
|
|
Invention
|
Composite preparation of mosapride and rabeprazole. The present invention relates to a composite ... |
|
|
P/S
|
Pharmaceutical agents affecting sensory organs;
pharmaceutical agents affecting metabolism; phar... |
|
2015
|
Invention
|
Medicine inhaler |
|
|
Invention
|
Pharmaceutical composition comprising gold-containing agent for preventing or treating liver fibr... |
|
|
Invention
|
Pharmaceutical composite preparation. The present invention relates to a composite preparation co... |
|
|
Invention
|
Oral sustained-release preparation. The present invention relates to a sustained-release cilostaz... |
|
2014
|
Invention
|
Solid preparations containing pelargonium sidoides extracts and silicic acid compound, and prepar... |
